ACAAI wishes you a Thanksgiving filled with gratitude and warmth
American College of Allergy, Asthma and Immunology (ACAAI)
Medical Practices
Arlington Heights, Illinois 3,642 followers
About us
The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit www.acaai.org. Information on this page does not constitute medical advice.
- Website
-
http://www.acaai.org
External link for American College of Allergy, Asthma and Immunology (ACAAI)
- Industry
- Medical Practices
- Company size
- 11-50 employees
- Headquarters
- Arlington Heights, Illinois
- Type
- Nonprofit
- Founded
- 1942
Locations
-
Primary
Get directions
85 W. Algonquin Rd.
Suite 550
Arlington Heights, Illinois 60005, US
Employees at American College of Allergy, Asthma and Immunology (ACAAI)
-
Christina Ciaccio
Mary Yovovich Professor of Pediatrics in the Wallman Society of Fellows and Executive Vice Chair of Pediatrics
-
Todd McGee
-
J. Allen Meadows
Executive Director of Advocacy and Governmental Affairs ACAAI Professor of Pediatrics, Division of Allergy & Immunology, UAB
-
Katy Allen
Education Program Specialist | CME Coordination | Joint Providership, Webinars & Podcasts
Updates
-
Too many patients stop at their primary care provider without ever reaching an allergist, missing out on critical care. That’s one of the key challenges Dr. Todd Mahr, our Executive Medical Director, discussed when he sat down with @Sanofi’s Piya Sircar for a conversation about how the American College of Allergy, Asthma and Immunology (ACAAI) is working to close those gaps. They talked about how ACAAI is working to: 🔷Elevate education for patients and primary care providers through new resources on Type 2 inflammation 🔷Help allergists connect with their communities through ready-to-use tools 🔷Support research and awareness around multiple allergic conditions 🔷Reinforce the vital role of collaboration across specialties to deliver better outcomes As allergists, we’re often the bridge between multiple conditions and care teams. Sharing knowledge and empowering both healthcare providers and patients is essential in this role. 🎥 I invite you to watch our full conversation: https://lnkd.in/gERaU6Mu #PatientAdvocacy #PatientEngagement #PatientAdvocacyVoices #AllergyPatients
ACAAI’s Todd Mahr on Educating Allergy Patients and Healthcare Providers | Patient Advocacy Voices
https://www.youtube.com/
-
2024-25 ACAAI President James M. Tracy, DO, FACAAI (right) hands the gavel to 2025-26 President Cherie Y. Zachary, MD, FACAAI (left). We thank Dr. Tracy for his dedication and service to ACAAI during his year as College President. #ACAAI25
-
-
Sponsored Content: Visit AstraZeneca booth #819 and click to learn more. https://lnkd.in/gb9tRN5H
-
-
Sponsored: Join #BradykininMediatedAngioedema Experts, at 7:45pm ET tonight, at @Pharvaris’ sponsored Corporate Forum “Pathways and Mechanism in Bradykinin-Mediated Angioedema: From Physiology to Practice”. Leading experts will explore the complexities of bradykinin-mediated angioedema from research findings to unmet needs in clinical practice.
-
-
Sponsored: Come see how DAWNZERA (donidalorsen) is advancing the science of antisense oligonucleotides (ASOs) and impacting clinical outcomes. Visit DAWNZERAHCP.com #sponsored https://dawnzerahcp.com/
-
-
Sponsored: Clorox will be touching down in Orlando, Florida to attend this year’s ACAAI Annual Meeting! Be sure to stop by Booth #1614 to meet with the Clorox team and learn about a new product innovation coming to the allergy space. See you at #ACAAI25!
-
-
Sponsored: Join expert panelists as Ionis introduces DAWNZERA (donidalorsen), a newly approved RNA-targeted therapy, to ACAAI. Learn more at the presentation or at the Ionis DAWNZERA booth. Visit DAWNZERAHCP.com #sponsored https://dawnzerahcp.com/
-
-
Attend the ACAAI Annual Scientific Meeting from home! See live broadcast of plenaries and symposia, participate in Q & A and get credit! Livestream program registration ends Nov. 5. https://lnkd.in/gbjSZNEq
-